CVR: 43575627
Ebumab Sandbox ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The company is owned by Ebumab Holding ApS. In 2025, the company reported a gross profit of DKK -12,630 and a net result of DKK -11,150 compared with DKK -7,800 the year before. Equity amounted to DKK 15,192.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er drive virksomhed indenfor forskning, udvikling og markedsføring af farmaceutiske og medicinske præparater samt anden efter bestyrelsens skøn beslægtet virksomhed.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Ebumab Sandbox ApS has published its annual report for 2025. Gross profit came to DKK -12,630, and the net result was DKK -11,150.
Ebumab Sandbox ApS has published its annual report for 2024. Gross profit came to DKK -10,000, and the net result was DKK -7,800.
As of February 25, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Ebumab Sandbox ApS.
As of February 25, 2025, Slotsgade Revision ApS has stepped down as auditor of Ebumab Sandbox ApS.
Ebumab Sandbox ApS has published its interim report for the period October 12, 2022 – December 31, 2023.
As of October 12, 2022, Slotsgade Revision ApS has been appointed auditor of Ebumab Sandbox ApS.
As of October 12, 2022, Hans Heugh Wandall has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Johan Henrik Faber has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Søren Erik Bjørn has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Hans Heugh Wandall is registered as adm. dir. of Ebumab Sandbox ApS.
As of October 12, 2022, Johan Henrik Faber is registered as director of Ebumab Sandbox ApS.
As of October 12, 2022, Ebumab Holding ApS is registered as an owner of Ebumab Sandbox ApS with an ownership share of 100%.
Ebumab Sandbox ApS was founded on October 12, 2022.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583